• Multi-year supply agreement for radium-226 processing and purification• Collaboration will work to provideAc-225 for clinical trials and commercial supply (OTTAWA, Ontario …
Menu
• Multi-year supply agreement for radium-226 processing and purification• Collaboration will work to provideAc-225 for clinical trials and commercial supply (OTTAWA, Ontario …
Each year, BWXT Medical submits a comprehensive Annual Compliance Report (ACR) to the Canadian Nuclear Safety Commission (CNSC) for its Kanata facility. …
(OTTAWA, Ontario – June 7, 2024) – BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and …
BWXT Medical conducts community surveys to obtain feedback on its public information program, including its strengths and key areas for improvement in …
Agreement Furthers BWXT Medical’s Position as a Global Leader in Actinium Supply Collaboration Enables Fusion to Produce High Purity Actinium-225 at its …
(Ottawa, Ontario – February 1, 2023) – Life-saving Molybdenum-99 (Mo-99) isotopes can now be produced at Ontario Power Generation’s (OPG) Darlington Nuclear …
Community Inquiries:
Phone: 1.833.657.4565
email: [email protected]
Job Seekers:
Please visit www.bwxt.com/careers
for current opportunities.
For urgent media inquiries, please contact:
Monifa Miller
Senior Director, Corporate Affairs
+1 519.242.8071
[email protected]
